Literature DB >> 28673113

Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - Commentary.

John R Corboy1.   

Abstract

Mesh：

Year:  2017        PMID： 28673113     DOI： 10.1177/1352458517717809

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis.

Authors:  Natalie A Schwehr; Karen M Kuntz; Mary Butler; Eva A Enns; Nathan D Shippee; Elaine Kingwell; Helen Tremlett; Adam F Carpenter
Journal:  Mult Scler       Date:  2019-07-29       Impact factor: 6.312

2.  Use and cost of disease-modifying therapies by Sonya Slifka Study participants: has anything really changed since 2000 and 2009?

Authors:  Sarah L Minden; R Philip Kinkel; Helene T Machado; Jonathan S Levin; Meredith B Rosenthal; Lisa I Iezzoni
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.